Lisa Ludwig

584 total citations · 1 hit paper
9 papers, 79 citations indexed

About

Lisa Ludwig is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Lisa Ludwig has authored 9 papers receiving a total of 79 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cancer Research. Recurrent topics in Lisa Ludwig's work include Renal cell carcinoma treatment (2 papers), Diabetes Treatment and Management (2 papers) and Cancer Genomics and Diagnostics (2 papers). Lisa Ludwig is often cited by papers focused on Renal cell carcinoma treatment (2 papers), Diabetes Treatment and Management (2 papers) and Cancer Genomics and Diagnostics (2 papers). Lisa Ludwig collaborates with scholars based in United States, United Kingdom and France. Lisa Ludwig's co-authors include Bruno Guerci, Patrice Darmon, Thomas Rémen, Laura Fernández Landó, Luis Nevárez Ruiz, Yanyun Chen, David A. Cox, Wen‐Shuo Wu, Rong Liu and Stanley H. Hsia and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Archives of Disease in Childhood.

In The Last Decade

Lisa Ludwig

8 papers receiving 77 citations

Hit Papers

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agoni... 2025 2026 2025 5 10 15 20
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
    2025 21 citations Julio Rosenstock, Stanley H. Hsia et al. New England Journal of Medicine profile →

Peers

Lisa Ludwig
Song Han South Korea
Takuya Haraguchi Japan
Monika Tomaszewska‐Kiecana Poland
S Butterworth United Kingdom
Charles J. Blijdorp Netherlands
Atiqa Miah Bangladesh
H. B. Bueno-de-Mesquita Netherlands
Mariano Dei Italy
RJ Hinchliffe United Kingdom
Song Han South Korea
Lisa Ludwig
Citations per year, relative to Lisa Ludwig Lisa Ludwig (= 1×) peers Song Han

Countries citing papers authored by Lisa Ludwig

Since Specialization
Citations

This map shows the geographic impact of Lisa Ludwig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Ludwig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Ludwig more than expected).

Fields of papers citing papers by Lisa Ludwig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Ludwig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Ludwig. The network helps show where Lisa Ludwig may publish in the future.

Co-authorship network of co-authors of Lisa Ludwig

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Ludwig. A scholar is included among the top collaborators of Lisa Ludwig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Ludwig. Lisa Ludwig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ludwig, Lisa, Scott N. Compton, Samuel Broderick, et al.. (2025). Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of Safety. Journal of Child and Adolescent Psychopharmacology. 35(6). 326–336.
2.
Rosenstock, Julio, Stanley H. Hsia, Luis Nevárez Ruiz, et al.. (2025). Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes. New England Journal of Medicine. 393(11). 1065–1076. 21 indexed citations breakdown →
3.
Navani, Vishal, J. Connor Wells, Devon J. Boyne, et al.. (2022). CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). Clinical Genitourinary Cancer. 21(1). 106.e1–106.e8. 12 indexed citations
4.
5.
6.
Ludwig, Lisa, Patrice Darmon, & Bruno Guerci. (2020). Computing and interpreting the Number Needed to Treat for Cardiovascular Outcomes Trials. Cardiovascular Diabetology. 19(1). 65–65. 16 indexed citations
7.
Patel, Mitul, et al.. (2016). HOW WELL DO OUTPATIENT PRESCRIPTIONS ADHERE TO GOOD ANTIMICROBIAL STEWARDSHIP?. Archives of Disease in Childhood. 101(9). e2.39–e2. 3 indexed citations
8.
Launay‐Vacher, Vincent, Nicolas Janus, Philippe Beuzeboc, et al.. (2015). Tolérance rénovasculaire du bévacizumab dans le cancer du sein. Valeur pronostique de l’hypertension et de la protéinurie. Bulletin du Cancer. 102(11). 906–914. 5 indexed citations
9.
Ludwig, Lisa, et al.. (1953). [Effect of aureomycin].. PubMed. 3(11). 559–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Song Han Breakdown of academic impact, for papers by Takuya Haraguchi Breakdown of academic impact, for papers by Monika Tomaszewska‐Kiecana Breakdown of academic impact, for papers by S Butterworth Breakdown of academic impact, for papers by Charles J. Blijdorp Breakdown of academic impact, for papers by Atiqa Miah Breakdown of academic impact, for papers by H. B. Bueno-de-Mesquita Breakdown of academic impact, for papers by Mariano Dei Breakdown of academic impact, for papers by RJ Hinchliffe
Rankless by CCL
2026